Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G J B Engels

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Netherlands Journal of Medicine|August 25, 2006
Mirizzi's syndromeM J B Aarts, L G J B Engels
Gut|April 16, 2005
Inflammatory bowel disease stimulates formation of carcinogenic N-nitroso compoundsT M C M de Kok, L G J B Engels, E J Moonen, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2010
Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control studyD Keszthelyi, S V Jansen, G A Schouten, et al.
Clinical Drug Investigation|May 26, 2007
Therapeutic drug monitoring in patients with inflammatory bowel disease and established azathioprine therapyL P L Gilissen, L J J Derijks, L P Bos, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Safe 6-thioguanine therapy of a TPMT deficient Crohn's disease patient by using therapeutic drug monitoringW G N Mares, D R Wong, L P L Gilissen, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 26, 2006
Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?L P L Gilissen, L J J Derijks, A Driessen, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2006
Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's diseaseL P L Gilissen, L J J Derijks, H M J H Verhoeven, et al.
Alimentary Pharmacology & Therapeutics|September 27, 2005
The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patientsL P L Gilissen, J Bierau, L J J Derijks, et al.
Clinics and Research in Hepatology and Gastroenterology|September 3, 2010
The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosisE M M Kuiper, B E Hansen, W Lesterhuis, et al.
Helicobacter|June 6, 2002
Helicobacter pylori does not mediate the formation of carcinogenic N-nitrosaminesI T M Vermeer, M M Gerrits, E J C Moonen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Netherlands Journal of Medicine|August 25, 2006
Mirizzi's syndromeM J B Aarts, L G J B Engels
Gut|April 16, 2005
Inflammatory bowel disease stimulates formation of carcinogenic N-nitroso compoundsT M C M de Kok, L G J B Engels, E J Moonen, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2010
Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control studyD Keszthelyi, S V Jansen, G A Schouten, et al.
Clinical Drug Investigation|May 26, 2007
Therapeutic drug monitoring in patients with inflammatory bowel disease and established azathioprine therapyL P L Gilissen, L J J Derijks, L P Bos, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Safe 6-thioguanine therapy of a TPMT deficient Crohn's disease patient by using therapeutic drug monitoringW G N Mares, D R Wong, L P L Gilissen, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 26, 2006
Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?L P L Gilissen, L J J Derijks, A Driessen, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2006
Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's diseaseL P L Gilissen, L J J Derijks, H M J H Verhoeven, et al.
Alimentary Pharmacology & Therapeutics|September 27, 2005
The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patientsL P L Gilissen, J Bierau, L J J Derijks, et al.
Clinics and Research in Hepatology and Gastroenterology|September 3, 2010
The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosisE M M Kuiper, B E Hansen, W Lesterhuis, et al.
Helicobacter|June 6, 2002
Helicobacter pylori does not mediate the formation of carcinogenic N-nitrosaminesI T M Vermeer, M M Gerrits, E J C Moonen, et al.
Pageof 2